<DOC>
	<DOCNO>NCT00737204</DOCNO>
	<brief_summary>This study determine whether armodafinil ( Nuvigil ) , FDA approve medication , effective reduce fatigue adult HIV/AIDS .</brief_summary>
	<brief_title>Effectiveness Armodafinil Treating Fatigue Adults With HIV/AIDS</brief_title>
	<detailed_description>Fatigue common problem many people HIV/AIDS , interfere daily activity serve significant barrier work among whose health otherwise stable restore antiretroviral ( ARV ) medication . Fatigue HIV associate disability diminish quality life . It may cause ARVs virus . A related study test whether modafinil , armodafinil r-isomer , could reduce fatigue HIV/AIDS patient . Armodafinil , believe long duration great effect modafinil , test criterion . Participants randomly assign receive either armodafinil placebo daily 4 week . Participants randomize active medication show improvement symptom offer armodafinil additional 12 week . For , study duration 16 week . Participants receive armodafinil offer armodafinil 16 week . For participant , study duration 20 week . Participants benefit armodafinil receive alternate treatment option . All participant weekly study visit first 4 week study biweekly visit remainder study . At visit , participant complete various task determine cognitive function , self-report scale use determine symptom depression fatigue . After completion 16 week , participant respond armodafinil transition publicly available modafinil course 2 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<criteria>1 . Ages 1875 2 . HIV+ 3 . Clinically significant fatigue ( score 4.5+ Fatigue Severity Scale , plus impairment 1+ category Role Function Scale ) 4 . Fatigue duration 3+ month 5 . Englishspeaking 6 . Able give inform consent 7 . Fecund woman use barrier method contraception 1 . Primary care doctor approve study participation 2 . Unstable medical condition ( e.g . liver failure ; cirrhosis , new onset opportunistic infection past month ) 3 . Untreated hypogonadism , except men testosterone replacement medically contraindicate ( serum testosterone reference range ) 4 . Untreated hypothyroidism ( Thyroid Stimulating Hormone 5 IUI/mL ) 5 . Untreated uncontrolled hypertension 6 . Clinically significant anemia ( hematocrit &lt; 30 % ) 7 . Started testosterone nandrolone past 6 week 8 . Started changed antiretroviral regimen past 4 week fatigue predate change ; otherwise , start change regimen past 2 month 9 . Untreated undertreated major depressive disorder 10 . Started antidepressant medication within past 6 week 11 . Substance abuse/dependence ( past 4 month ) 12 . Regular frequent cannabis use ( &gt; twice/week regularly ) 13 . Currently clinically significant suicidal ideation Hamilton Depression Scale ( HAMD ) score &gt; 24 14 . History current psychosis bipolar disorder 15 . Pregnant breastfeed 16 . Significant untreated insomnia ( score &gt; 3 HAMD insomnia item ) 17 . Currently take psychostimulant medication past nonresponse modafinil 18 . Has alternative viable antiretroviral regimen current one 19 . Left ventricular hypertrophy ; mitral valve prolapse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Armodafinil</keyword>
	<keyword>Depression</keyword>
</DOC>